Gladstone McDowell, MD
Interventional Pain Medicine · Columbus, OHNPI 1346296621
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $406,840 of the $660,303 with a category attached, or 61.6%. Tersera Therapeutics LLC accounts for 89.0% of it on its own, with 42 other manufacturers making up the rest. 2025 is the largest year on record at $286,606, 5.6 times the $51,244 reported in 2019. Among interventional pain medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,300 payments — averaging $507.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tersera Therapeutics LLC$588K
- Nevro Corp.$34K
- Flowonix Medical Incorporated$16K
- Medtronic$9K
- Stimwave Technologies Incorporated$5K
- Boston Scientific$2K
- plus $7K from 37 others
Across 75 payments — averaging $1255.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$55K
- Medtronic$33K
- Biotronik Inc.$3K
- Flowonix Medical Incorporated$2K
What the payments were for
- Consulting fees$406,84062%
- Speaking & faculty fees$129,18220%
- Travel & lodging$103,21516%
- Food & beverage$21,0373%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIALT$570,675
- Senza Spinal Cord Stimulation System$31,046
- Prometra II$15,561
- SYNCHROMED$7,765
- QUZYTTIR$2,592
- Omnia$1,512
- HA MINUTEMAN G3-R$1,027
- CFNS StimQ Peripheral Nerve StimulatorSystem$416
- SCS FreedonSpinal Cord Stimulator$416
- PROCLAIM$341
- GENERAL - THERAPIES$237
- SYNCHROMEDII$234
- mild Device Kit$228
- GENERAL PAIN MANAGEMENT$209
- Evoke$154
- Neuromodulation Dspsbls and Accs$142
- Proclaim Family of SCS IPGs$139
- InSpan$115
- SacroFuse$115
- NanoFuse Putty$115
How this compares
$660,303 in reported general payments places this provider in the 95th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 18 | $185 |
| Tizanidine Hcl | 53 | $163 |
| Topiramate | 13 | $117 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Columbus
- David WalegaColumbus$37K
- Steven BhutraColumbus$13K
- Jayesh VallabhColumbus$4K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Jaudat MahmoodKent$97K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.